FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


19439 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Leptospirosis risk exposure (& [Weil's disease]) At increased risk of exposure to Leptospira
Leptospirosis risk exposure (& [Weil's disease]) At increased risk of exposure to Leptospira
Leptospirosis risk exposure At increased risk of exposure to Leptospira
Lepus victoriae Lepus microtis subspecies microtus (organism)
Lethal neonatal spasticity Lethal neonatal spasticity, epileptic encephalopathy syndrome (disorder)
Letterer-Siwe disease of extranodal AND/OR solid organ site Langerhans cell histiocytosis, disseminated (disorder)
Letterer-Siwe disease of intra-abdominal lymph nodes Disseminated Langerhans cell histiocytosis of abdominal lymph nodes (disorder)
Letterer-Siwe disease of intrapelvic lymph nodes Disseminated Langerhans cell histiocytosis of pelvic lymph nodes (disorder)
Letterer-Siwe disease of intrathoracic lymph nodes Disseminated Langerhans cell histiocytosis of lymph nodes of thorax (disorder)
Letterer-Siwe disease of lymph nodes of axilla AND/OR upper limb Disseminated Langerhans cell histiocytosis of lymph nodes of upper limb (disorder)
Letterer-Siwe disease of lymph nodes of axilla and upper limb Disseminated Langerhans cell histiocytosis of lymph nodes of upper limb (disorder)
Letterer-Siwe disease of lymph nodes of head Disseminated Langerhans cell histiocytosis of lymph nodes of head (disorder)
Letterer-Siwe disease of lymph nodes of inguinal region AND/OR lower limb Disseminated Langerhans cell histiocytosis of lymph nodes of lower limb (disorder)
Letterer-Siwe disease of lymph nodes of inguinal region and lower limb Disseminated Langerhans cell histiocytosis of lymph nodes of lower limb (disorder)
Letterer-Siwe disease of lymph nodes of lower limb Disseminated Langerhans cell histiocytosis of lymph nodes of lower limb (disorder)
Letterer-Siwe disease of lymph nodes of multiple sites Disseminated Langerhans cell histiocytosis of lymph nodes of multiple sites (disorder)
Letterer-Siwe disease of lymph nodes of neck Disseminated Langerhans cell histiocytosis of cervical lymph nodes (disorder)
Letterer-Siwe disease of lymph nodes of upper limb Disseminated Langerhans cell histiocytosis of lymph nodes of upper limb (disorder)
Letterer-Siwe disease of spleen Disseminated Langerhans cell histiocytosis of spleen (disorder)
Letterer-Siwe's disease Langerhans cell histiocytosis, disseminated (morphologic abnormality)
Lettuce - dietary Lettuce (substance)
Leucaena glauca Leucaena leucocephala
Leucodystrophy without a known biochemical basis Leucodystrophy
Leuconostoc fructosum Fructobacillus fructosus (organism)
Leuconostoc garviae Lactococcus garvieae (organism)
Leuconostoc oenos Oenococcus oeni
Leuconostoc paramesenteroides Weissella paramesenteroides
Leucotomy NEC Leukotomy
Leukaemia - specif. cell NOS Leukaemia
Leukaemia of unspecified cell type Leukaemia
Leukemia - category Leukaemia
Leukemia - specific cell NOS Leukaemia
Leukemia of unspecified cell type Leukaemia
Leukemia, no International Classification of Diseases for Oncology subtype Leukaemia
Leukemic reticuloendotheliosis Hairy cell leukemia
Leukemic reticuloendotheliosis of extranodal AND/OR solid organ site Hairy cell leukemia
Leuprolide acetate 11.25mg Leuprorelin acetate 7.5 mg/mL suspension for injection
Leuprolide acetate 11.25mg injection Leuprorelin acetate 7.5 mg/mL suspension for injection
Leuprolide acetate 11.25mg powder for injection suspension vial Leuprorelin acetate 7.5 mg/mL suspension for injection
Leuprolide acetate 15mg powder and solvent for injection suspension vial Leuprorelin only product in parenteral dose form
Leuprolide acetate 15mg powder for injection suspension vial Leuprorelin only product in parenteral dose form
Leuprolide acetate 22.5mg Leuprorelin only product in parenteral dose form
Leuprolide acetate 22.5mg powder for injection suspension vial Leuprorelin only product in parenteral dose form
Leuprolide acetate 30mg Leuprorelin acetate 20 mg/mL suspension for injection
Leuprolide acetate 30mg powder for injection suspension vial Leuprorelin acetate 20 mg/mL suspension for injection
Leuprolide acetate 45mg powder for injection suspension vial Product containing precisely leuprorelin acetate 120 milligram/1 milliliter conventional release suspension for injection (clinical drug)
Leuprolide acetate 7.5mg Leuprorelin acetate 7.5 mg/mL suspension for injection
Leuprolide acetate 7.5mg injection Leuprorelin acetate 7.5 mg/mL suspension for injection
Leuprolide acetate 7.5mg powder for injection suspension vial Leuprorelin acetate 7.5 mg/mL suspension for injection
Levafix black Textile colours and finishes patch test substance
Levafix brilliant blue Textile colours and finishes patch test substance
Levafix brilliant yellow Textile colours and finishes patch test substance
Levafix dye Textile colours and finishes patch test substance
Levafix marinblau Textile colours and finishes patch test substance
Levalbuterol 45mcg hfa metered dose aerosol inhaler Product containing only levosalbutamol (medicinal product)
Levobetaxolol hydrochloride 0.5% ophthalmic suspension Levobetaxolol 5 mg/mL eye suspension
Levobunolol hydrochloride 0.5% conventional release eye drops Levobunolol hydrochloride 5 mg/mL eye solution
Levobunolol hydrochloride 0.5% single-use eye drops Levobunolol hydrochloride 5 mg/mL eye solution
Levobupivacaine 1.25mg/mL injection solution 200mL bag Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 1.25 milligram/1 milliliter conventional release solution for injection (clinical drug)
Levocetirizine 2.5mg/5mL oral solution Levocetirizine dihydrochloride 500 microgram/mL oral solution
Levofloxacin 1.5% ophthalmic solution Product containing precisely levofloxacin anhydrous (as levofloxacin) 15 milligram/1 milliliter conventional release eye solution (clinical drug)
Levofloxacin 25mg/mL oral solution Product containing precisely levofloxacin anhydrous (as levofloxacin) 25 milligram/1 milliliter conventional release oral solution (clinical drug)
Levofloxacin 5mg/mL infusion solution 100mL vial Levofloxacin 5 mg/mL solution for injection
Levofloxacin 5mg/ml ophthalmic solution Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution
Levoleucovorin calcium 50mg powder for injection solution vial Levoleucovorin (as levoleucovorin calcium) 50 mg powder for solution for injection vial
Levomethadyl acetate hydrochloride 10mg/mL oral solution Levomethadyl 10 mg/mL oral solution
Levonorgestrel 0.015mg/day + estradiol 0.045mg/day transdermal system Estradiol 1.88 microgram/hour and levonorgestrel 625 nanogram/hour prolonged-release transdermal patch
Levonorgestrel 52mg intrauterine system Product containing precisely levonorgestrel 833 nanogram/1 hour prolonged-release intrauterine drug delivery system (clinical drug)
Levothyroxine sodium 0.05mg tablet Levothyroxine sodium anhydrous 50 microgram oral tablet
Levothyroxine sodium 0.075mg tablet Levothyroxine sodium anhydrous 75 microgram oral tablet
Levothyroxine sodium 0.1mg tablet Levothyroxine sodium anhydrous 100 microgram oral tablet
Levothyroxine sodium 200mg tablet Product containing precisely levothyroxine sodium 200 microgram/1 each conventional release oral tablet (clinical drug)
Levothyroxine sodium o.05mg Levothyroxine sodium anhydrous 50 microgram oral tablet
Leydig cell neoplasm of testis Leydig cell tumor of testis of uncertain behavior
Leydig cell tumor, no International Classification of Diseases for Oncology subtype Leydig cell tumor of uncertain behavior (morphologic abnormality)
Lichen NOS Lichen (disorder)
Lichen NOS Lichen (disorder)
Lichen sclerosus et atrophicus Lichen sclerosus
Lichen sclerosus et atrophicus of the vulva Lichen sclerosus of vulva (disorder)
Lichen sclerosus et atrophicus, bullous type Lichen sclerosus bullous type (disorder)
Liddle's syndrome Pseudoprimary hyperaldosteronism (disorder)
Lidocaine 1%/epinephrine (1:200000) injection solution 20mL vial Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form)
Lidocaine 1.5% injection solution vial Lidocaine only product in parenteral dose form
Lidocaine 2%/epinephrine (1:200000) injection solution 20mL vial Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug)
Lidocaine 2.5% topical ointment Lidocaine hydrochloride 25 mg/g cutaneous ointment
Lidocaine 2.5%/prilocaine 2.5% periodontal gel Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel
Lidocaine hydrochloride 0.1%/glucose 5% infusion solution bag Product containing precisely lidocaine hydrochloride 1 milligram/1 milliliter conventional release solution for injection (clinical drug)
Lidocaine hydrochloride 0.2%/glucose 5% infusion solution bag Lidocaine hydrochloride 2 mg/mL solution for injection
Lidocaine hydrochloride 0.4%/glucose 5% infusion solution bag Lidocaine only product in parenteral dose form
Lidocaine hydrochloride 0.5% injection solution ampule Lidocaine only product in parenteral dose form
Lidocaine hydrochloride 0.5% injection solution vial Lidocaine only product in parenteral dose form
Lidocaine hydrochloride 0.6%/glucose 5% infusion solution bag Product containing precisely lidocaine hydrochloride 6 milligram/1 milliliter conventional release solution for injection (clinical drug)
Lidocaine hydrochloride 1% conventional release solution for injection ampule Lidocaine only product in parenteral dose form
Lidocaine hydrochloride 1% injection Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Lidocaine hydrochloride 1% injection solution ampule Lidocaine only product in parenteral dose form
Lidocaine hydrochloride 1% injection solution sterile ampule Lidocaine only product in parenteral dose form
Lidocaine hydrochloride 1% injection solution vial Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Lidocaine hydrochloride 1%/epinephrine 1:100,000 injection solution vial Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection
Lidocaine hydrochloride 1%/epinephrine 1:200,000 injection solution vial Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form)
Lidocaine hydrochloride 1.5% injection solution ampule Lidocaine only product in parenteral dose form
Lidocaine hydrochloride 1.5%/epinephrine 1:200,000 injection solution vial Product containing only epinephrine and lidocaine in parenteral dose form (medicinal product form)

Start Previous Page 88 of 195 Next End


Reference Sets

Reference set descriptor

Back to Start